These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23249712)

  • 1. Murine infection models for vaccine development: the malaria example.
    Matuschewski K
    Hum Vaccin Immunother; 2013 Mar; 9(3):450-6. PubMed ID: 23249712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered, attenuated whole-cell vaccine approaches for malaria.
    Vaughan AM; Wang R; Kappe SH
    Hum Vaccin; 2010 Jan; 6(1):107-13. PubMed ID: 19838068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-Directed AAV8 Booster Vaccine Expressing
    Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
    Front Immunol; 2021; 12():612910. PubMed ID: 34248928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
    Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of transgenic parasites in malaria vaccine research.
    Othman AS; Marin-Mogollon C; Salman AM; Franke-Fayard BM; Janse CJ; Khan SM
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine candidate discovery for the next generation of malaria vaccines.
    Tuju J; Kamuyu G; Murungi LM; Osier FHA
    Immunology; 2017 Oct; 152(2):195-206. PubMed ID: 28646586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Development of Whole Sporozoite Vaccines for
    Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK
    Front Immunol; 2018; 9():2748. PubMed ID: 30619241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
    Bettencourt P
    Front Immunol; 2020; 11():190. PubMed ID: 32153565
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeys.
    De SL; Stanisic DI; van Breda K; Bellete B; Harris I; McCallum F; Edstein MD; Good MF
    Int J Parasitol; 2016 Aug; 46(9):581-91. PubMed ID: 27238088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.
    Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF
    BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
    Epstein JE; Richie TL
    Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine.
    Luke TC; Hoffman SL
    J Exp Biol; 2003 Nov; 206(Pt 21):3803-8. PubMed ID: 14506215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum Antigen Expression in Leishmania Parasite: A Way Forward for Live Attenuated Vaccine Development.
    Srivastava A; Garg S; Karan S; Kaushik S; Ranganathan A; Pati S; Garg LC; Singh S
    Methods Mol Biol; 2022; 2410():555-566. PubMed ID: 34914067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical and clinical development of the first placental malaria vaccine.
    Pehrson C; Salanti A; Theander TG; Nielsen MA
    Expert Rev Vaccines; 2017 Jun; 16(6):613-624. PubMed ID: 28434376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria.
    Mo AX; Pesce J; Hall BF
    Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination With Sporozoites: Models and Correlates of Protection.
    Goh YS; McGuire D; Rénia L
    Front Immunol; 2019; 10():1227. PubMed ID: 31231377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hope but challenge for developing a vaccine that might control malaria.
    Good MF
    Eur J Immunol; 2009 Apr; 39(4):939-43. PubMed ID: 19350585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Strategies for Malaria Vaccine Design.
    Frimpong A; Kusi KA; Ofori MF; Ndifon W
    Front Immunol; 2018; 9():2769. PubMed ID: 30555463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.
    Richie TL; Billingsley PF; Sim BK; James ER; Chakravarty S; Epstein JE; Lyke KE; Mordmüller B; Alonso P; Duffy PE; Doumbo OK; Sauerwein RW; Tanner M; Abdulla S; Kremsner PG; Seder RA; Hoffman SL
    Vaccine; 2015 Dec; 33(52):7452-61. PubMed ID: 26469720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.